Skip to content

Clinical application of intravascular hypothermia in patients with severe aneurysmal subarachnoid hemorrhage

Clinical application of intravascular hypothermia in patients with severe aneurysmal subarachnoid hemorrhage

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049596
Enrollment
Unknown
Registered
2021-08-06
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subarachnoid hemorrhage

Interventions

Test group:Intravascular hypothermia therapy

Sponsors

Henan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years old; 2. The first CT scan or lumbar puncture on admission confirmed the diagnosis of subarachnoid hemorrhage; 3. Routinely accepted digital subtraction angiography (DSA) or CTA within 72 hours after hospitalization to diagnose intracranial aneurysm; 4. Received intracranial aneurysm craniotomy, interventional embolization or compound surgery within 72 hours; 5. Hunt-Hess classification level III or above; 6. The patient's family signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Over 80 years old; 2. Patients with systemic inflammatory response syndrome or sepsis at the time of enrollment; 3. Have a history of hematological diseases, bleeding constitution, coagulation dysfunction, check prothrombin time (PT)>15s, activated partial thromboplastin time (APTT)>40s, international normalized ratio (INR)>1.4, platelet count (PLT)<100x10^9/L; 4. Major surgery or trauma history within the past three months; 5. A history of gastrointestinal ulcer in the past three months, and a history of urinary system bleeding in the past three weeks; 6. Intracerebral hemorrhage or myocardial infarction occurred in the past three months; 7. Pregnancy and lactation patients; 8. Patients with autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
Good prognosis rate;

Secondary

MeasureTime frame
Glasgow Coma Index Score;National Institutes of Health Neurological Impairment Score (NIHSS) score;

Countries

Zhongguo

Contacts

Public ContactFeng Guang

Henan Provincial People's Hospital

fgwxh@163.com+86 18903711799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026